IndustryARC™

Indian Pharmaceutical Market guidelines - research and analysis illuminated by new report 2015

Press Release   •   Nov 18, 2016 14:34 EST

This report discusses the Indian pharmaceutical industry in depth, with specific focus on the ten leading domestic India pharmaceutical companies; their key financials since FY2011; their key global markets; their Merger, Acquisition and Joint Venture activity; their Research & Development spending; as well as Strength, Weakness, Opportunity and Threats that each individual company faces. This report also offers a snapshot of the key financials in the India pharmaceutical sector; import / export values, and where the India based pharmaceutical companies are generating their revenue globally. The report concludes with interviews with directors of Ipca Laboratories, Cadila Healthcare and Cipla.


Check Complete Report @
http://www.marketintelreports.com/report/in10pharm/the-indian-pharmaceutical-market--leading-domestic-companies-2015


The Indian Pharmaceutical Market - Leading Domestic Companies 2015 also highlights what drives, or restrains, the market for these leading companies;

Key Drivers

  • US Generics Market
  • JV, Acquisitions & Mergers
  • Patent Cliff
  • Increased Domestic Health Spending
  • Geographic Expansion into Semi-Regulated and Emerging Pharma Markets
  • Economies in Drug Production/Manufacture
  • Governmental Support


Get Sample Brochure of the Report @
http://www.marketintelreports.com/pdfdownload.php?id=in10pharm


Key Restraints

  • Industry Inefficiencies
  • Regulatory Non-Compliance
  • Price Ceilings
  • Intellectual Property Rights / Compulsory Licence
  • Inadequate Health Insurance, India

The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in list generating over 50% of their annual revenues from the US generics market. However with access to the US market comes increased scrutiny from the US FDA; nearly all the companies in the top ten have faced warnings from the FDA; ranging from minor procedural infractions to complete manufacturing shutdown.

The report contains over 130 tables & figures across 152 pages and concludes with 3 exclusive interviews with managing directors of 3 leading Indian pharmaceutical companies;

  • Cipla
  • Cadila Healthcare
  • IPCA Laboratories


Order a copy of Indian Pharmaceutical Market Report
now @ http://www.marketintelreports.com/purchase.php?id=in10pharm

About us:

MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.

A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.

MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.

MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.

Contact us:
Mayur S
Sales Manager

2711 Centerville Road, Suite 400,
Wilmington,
Delaware,
19808
United States
www.marketintelreports.com
sales@marketintelreports.com
Telephone: 1-302-261-5343